BIOMAT Database Logo BIOMAT Database Logo

[HL-A-B 27 in Reiter's disease with special reference to oligosymptomatic course forms]. 1977

C E Lange, and N Müller

In 21 patients with the clinical suspicion of oligosymptomatic R.S.), 21 patients with the clinical suspicion of oligosymptomatic R.S. and 16 patients with recurrent non-gonococcal urethritis 23 HLA-antigens were assessed using a lymphocyte toxicity test. 413 blood donors served as a controll group. 85,7% of the patients with R.S. had phenotyp HLA-B 27 compared with 7,4% of the controll persons. The group with the suspicion of R.S. exhibited with 57,1% a marked increased incidense of HLA-B 27 as well. Compared to this, the HLA-B 27 frequency in the patients with recurrent non-gonococcal urethritis was with 6,3% in especially of its oligosymptomatic courses. Because of the close association between HLA-B 27 and R.S. determination of histocompatibility antigens proved to be a valuable tool in the diagnosis of Reiter's disease, especially of its oligosymptomatic courses.

UI MeSH Term Description Entries
D008214 Lymphocytes White blood cells formed in the body's lymphoid tissue. The nucleus is round or ovoid with coarse, irregularly clumped chromatin while the cytoplasm is typically pale blue with azurophilic (if any) granules. Most lymphocytes can be classified as either T or B (with subpopulations of each), or NATURAL KILLER CELLS. Lymphoid Cells,Cell, Lymphoid,Cells, Lymphoid,Lymphocyte,Lymphoid Cell
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D006680 HLA Antigens Antigens determined by leukocyte loci found on chromosome 6, the major histocompatibility loci in humans. They are polypeptides or glycoproteins found on most nucleated cells and platelets, determine tissue types for transplantation, and are associated with certain diseases. Human Leukocyte Antigen,Human Leukocyte Antigens,Leukocyte Antigens,HL-A Antigens,Antigen, Human Leukocyte,Antigens, HL-A,Antigens, HLA,Antigens, Human Leukocyte,Antigens, Leukocyte,HL A Antigens,Leukocyte Antigen, Human,Leukocyte Antigens, Human
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012737 Sex Factors Maleness or femaleness as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or effect of a circumstance. It is used with human or animal concepts but should be differentiated from SEX CHARACTERISTICS, anatomical or physiological manifestations of sex, and from SEX DISTRIBUTION, the number of males and females in given circumstances. Factor, Sex,Factors, Sex,Sex Factor

Related Publications

C E Lange, and N Müller
Reiter's disease and HL-A 27.
September 1973, Lancet (London, England),
C E Lange, and N Müller
Reiter's disease and HL-A 27.
November 1973, Lancet (London, England),
C E Lange, and N Müller
[Early diagnosis of glomerulonephritis with special reference to the oligosymptomatic forms].
April 1974, Vnitrni lekarstvi,
C E Lange, and N Müller
HL-A 27 in Reiter's disease and psoriatic arthropathy.
January 1975, International journal of dermatology,
C E Lange, and N Müller
Reiter's disease and the histocompatibility antigen, HL-A 27.
January 1975, Scandinavian journal of rheumatology,
C E Lange, and N Müller
HL-A 27 and Reiter's syndrome.
September 1973, Lancet (London, England),
C E Lange, and N Müller
[Reiter's disease and HLA-B 27].
February 1979, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
C E Lange, and N Müller
HL-A antigens (17, 27, UPS) in psoriasis with special reference to patients with arthritic lesions.
January 1975, Acta dermato-venereologica,
C E Lange, and N Müller
[A special kind of course of Reiter's disease].
January 1953, Dermatologica,
C E Lange, and N Müller
HL-A 27 in reactive arthritis. A study of Yersinia arthritis and Reiter's disease.
January 1974, Arthritis and rheumatism,
Copied contents to your clipboard!